Literature DB >> 11476240

An immunoassay for small analytes with theoretical detection limits.

N Ohmura1, S J Lackie, H Saiki.   

Abstract

A flow-based immunoassay that uses microspheres as the solid phase accomplished the theoretical limit of detectability achievable with the antibody. An equilibrated mixture of anti-estriol monoclonal antibody and estriol was briefly exposed to a bead pack containing immobilized estriol in a flow cell. A small portion of free antibody was separated rapidly from the mixture by binding it to immobilized hormone, but the antibody-hormone complex was kinetically excluded from binding. This rapid separation prevented shift in the equilibrium of the liquid phase binding. Signals were generated by labeling the separated antibodies on the beads with a Cy5-conjugated antispecies secondary antibody. By labeling after the separation step, perturbing the liquid-phase or solid-phase binding was prevented. This assay allowed the reduction of the concentration of primary antibody by continuously accumulating free antibody onto the beads prior to quantification and, thus, offered ideal conditions to achieve theoretical limits of detectability. The optimum achievable dynamic range of this immunoassay was 4-300 pM. Because the proportion of free anti-estriol antibody in the mixture was controlled by the Kd of the antibody-estriol interaction, when the concentration of the antibody was below the Kd, the smallest detectable estriol concentration approached the theoretical limit of detectability achievable with this antibody.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476240     DOI: 10.1021/ac001328d

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  9 in total

Review 1.  Vaccines targeting drugs of abuse: is the glass half-empty or half-full?

Authors:  Kim D Janda; Jennifer B Treweek
Journal:  Nat Rev Immunol       Date:  2011-12-16       Impact factor: 53.106

2.  Dielectrically Addressable Microspheres Engineered Using Self-Assembled Monolayers.

Authors:  Jody Vykoukal; Daynene Mannering Vykoukal; Susan Sharma; Frederick F Becker; Peter R C Gascoyne
Journal:  Langmuir       Date:  2003-03-18       Impact factor: 3.882

3.  Immunopharmacotherapeutic manifolds and modulation of cocaine overdose.

Authors:  Jennifer B Treweek; Amanda J Roberts; Kim D Janda
Journal:  Pharmacol Biochem Behav       Date:  2011-02-26       Impact factor: 3.533

4.  Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin.

Authors:  Xianzhe Wang; James A Stapleton; Justin R Klesmith; Erik L Hewlett; Timothy A Whitehead; Jennifer A Maynard
Journal:  Biochemistry       Date:  2017-02-23       Impact factor: 3.162

5.  Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors.

Authors:  Yasmina Noubia Abdiche; Dan Stephen Malashock; Jaume Pons
Journal:  Protein Sci       Date:  2008-05-27       Impact factor: 6.725

6.  Theoretical limitations of quantification for noncompetitive sandwich immunoassays.

Authors:  Christine F Woolley; Mark A Hayes; Prasun Mahanti; S Douglass Gilman; Tom Taylor
Journal:  Anal Bioanal Chem       Date:  2015-09-05       Impact factor: 4.142

7.  Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteins.

Authors:  Nicole J Yang; Monique J Kauke; Fangdi Sun; Lucy F Yang; Katie F Maass; Michael W Traxlmayr; Yao Yu; Yingda Xu; Robert S Langer; Daniel G Anderson; K Dane Wittrup
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

8.  Kinetic Exclusion Assay of Biomolecules by Aptamer Capture.

Authors:  Mark H Smith; Daniel Fologea
Journal:  Sensors (Basel)       Date:  2020-06-18       Impact factor: 3.576

9.  Fast Detection of 2,4,6-Trinitrotoluene (TNT) at ppt Level by a Laser-Induced Immunofluorometric Biosensor.

Authors:  Martin Paul; Georg Tscheuschner; Stefan Herrmann; Michael G Weller
Journal:  Biosensors (Basel)       Date:  2020-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.